Mihoko Mizuno

15 papers receiving 294 citations

Peers

Mihoko Mizuno
Comparison fields: 5 of 65
  • Surgery 88
  • Molecular Biology 86
  • Endocrinology, Diabetes and Metabolism 58
  • Cardiology and Cardiovascular Medicine 53
  • Rheumatology 52
Replace Harry Yu with:
Harry Yu United States
Noriko Fujita Japan
Lorenza Montagna Italy
Gui Hua Wang China
Saliha Aksun Türkiye
Dietmar Plonné Germany
Xiao Lei Moore Australia
Ramesh Saeedi Canada
Amanda Baer United States
Yannick Renaud Canada
Mihoko Mizuno relative to Harry Yu United States Harry Yu's profile →
Citations per field
00.5×4.5×
Harry Yu · 1×
Citations per year

Countries citing papers authored by Mihoko Mizuno

Since Specialization
Citations

This map shows the geographic impact of Mihoko Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mihoko Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mihoko Mizuno more than expected).

Fields of papers citing papers by Mihoko Mizuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mihoko Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mihoko Mizuno. The network helps show where Mihoko Mizuno may publish in the future.

Co-authorship network of co-authors of Mihoko Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Mihoko Mizuno. A scholar is included among the top collaborators of Mihoko Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mihoko Mizuno. Mihoko Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 2
2 2
3 2
4 6
5 10
6 14
7 17
8 34
9 18
10
[Prevalence of sensitization of Japanese cedar pollen in children from infancy to adolescence].
7
11 97
12 30
13
9
14 47
15
[Combined chemotherapy of CDDP and etoposide in intracranial germinomas].
1

About Mihoko Mizuno

Mihoko Mizuno is a scholar working on Immunology and Allergy, Dermatology and Critical Care and Intensive Care Medicine, having authored 15 papers that have together received 296 indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (2 papers), Respiratory viral infections research (2 papers) and Dermatology and Skin Diseases (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (58 citations), Rheumatology (52 citations) and Clinical Biochemistry (22 citations). Mihoko Mizuno has collaborated with scholars based in Japan, Taiwan and Netherlands. Frequent co-authors include Masa‐aki Kawashiri, Akihiro Inazu, Hiroshi Mabuchi, Shoji Katsuda, Junji Kobayashi, Atsushi Nohara, Junji Koizumi, Toshinori Higashikata, Kenji Miwa and Hajime Togari. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026